Join us Professional membership
Keep In Touch

Add Your Email:

Latest News

Tocilizumab approved for GCA patients in US

Posted: 5 June 2017

The US Food and Drug Administration (FDA) on 22 May expanded the approved use of Roche’s Actemra (tocilizumab) to treat adults with giant cell arteritis, making it the first FDA-approved therapy for this condition.

European equivalent of FDA is EMA.

In the UK tocilizumab needs licensing first (=EMA), then NICE makes a recommendation re NHS funding which is a separate issue.

Read about Tocilizumab

See all news entries

Valid XHTML 1.0 Strict Valid CSS!

Site by Desktop Solutions